Ventricular septal defect 2

Common Name(s)

Ventricular septal defect 2

Ventricular septal defect type 2 (VSD type 2) is a heart condition present at birth (congenital) where there is a hole in the wall or septum that separates the ventricles (bottom two chambers of the heart). The septum separates oxygenated blood from deoxygenated blood. Normally, the holes in the septum close before the baby is born, but VSD is a common heart birth defect. In VSD type 2, the defect is in the upper section of the ventricular septum. If the hole is very small, it may not affect how hard the heart has to work, and your baby may not have symptoms. Sometimes a VSD is not diagnosed until childhood or even adulthood.

Often, symptoms are present as soon as a few days after birth and include poor eating, fast breathing, breathlessness, and getting tired easily. VSDs often occur in families (hereditary) or with other genetic conditions. Medical researchers believe most VSDs are caused by a combination of genetic and environmental factors. Type 2 is the most common VSD, accounting for at least 70% of VSD cases in most of the world (Type 1 accounts for 1/3 of VSDs in Asia).

Doctors may hear a swishing sound in the heartbeat (a murmur) when listening with a stethoscope. Tests used to confirm a VSD may include a chest X-ray, electrocardiogram (EKG) (tests the electrical impulses), echocardiogram (used sound waves to create a picture), or cardiac MRI.

Medications may be used temporarily to increase heart function, but surgical repair is the most common treatment. Smaller defects may close on their own. If your baby or child has been diagnosed with VSD Type 2, talk to their pediatric cardiologist (a heart doctor for children) about the most current treatment options. Support organizations and genetic counselors are also a good source of information and can help connect you with others affected by VSDs.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Ventricular septal defect 2" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Ventricular septal defect 2" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Ventricular septal defect 2" returned 10 free, full-text research articles on human participants. First 3 results:

Case 2/2015 a 33-year-old woman with double right ventricular chamber and ventricular septal defect.
 

Author(s): Edmar Atik

Journal: Arq. Bras. Cardiol.. 2015 Feb;104(2):e12-4.

 

Last Updated: 2 Apr 2015

Go To URL
A novel mutation of Hyaluronan synthase 2 gene in Chinese children with ventricular septal defect.
 

Author(s): Xiaomei Zhu, Xiaopeng Deng, Guangying Huang, Jing Wang, Jingwen Yang, Si Chen, Xu Ma, Binbin Wang

Journal:

 

As a major product of extracellular matrix (ECM), Hyaluronic acid (HA) is involved in early cardiac development and mainly synthesized by Hyaluronan synthase 2 (HAS2) during embryogenesis. Targeted deletion of HAS2 gene in mice led to obvious cardiac and vascular defects. To clarify ...

Last Updated: 21 Feb 2014

Go To URL
Prenatal diagnosis of mosaic trisomy 2 associated with abnormal maternal serum screening, oligohydramnios, intrauterine growth restriction, ventricular septal defect, preaxial polydactyly, and facial dysmorphism.
 

Author(s): Chih-Ping Chen, Yi-Yung Chen, Schu-Rern Chern, Peih-Shan Wu, Jun-Wei Su, Yu-Ting Chen, Chen-Chi Lee, Li-Feng Chen, Wayseen Wang

Journal: Taiwan J Obstet Gynecol. 2013 Sep;52(3):395-400.

 

To present prenatal diagnosis of mosaic trisomy 2.

Last Updated: 30 Sep 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Ventricular septal defect 2" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.
 

Status: Not yet recruiting

Condition Summary: Ventricular Septal Defect

 

Last Updated: 23 Sep 2016

Go to URL